StocktoriaQuoin Pharmaceuticals, Ltd. QNRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | — | — | — | — | $0 |
| Net income | -$15.8M | -$9.0M | -$8.7M | -$9.4M | -$21.5M |
| Operating cash flow | -$13.5M | -$7.9M | -$7.9M | -$8.5M | -$5.7M |
| Total assets | $20.4M | $15.7M | $12.2M | $14.5M | $9.4M |
| Total liabilities | $7.3M | $6.5M | $6.5M | $7.1M | $8.7M |
| Shareholders' equity | $13.1M | $9.2M | $5.7M | $7.4M | $657,032 |
| Ratios | |||||
| Return on assets | -77.5% | -57.1% | -71.4% | -64.9% | -229.4% |
| Return on equity | -120.5% | -97.4% | -153.4% | -126.7% | -3266.6% |
| Current ratio | 3.61 | 3.57 | 3.15 | 3.79 | 1.79 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001671502 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.